Digestive health

The Symptoms That Earn a Colonoscopy

Save

Alarm features are the short list that changes the plan. They are not a prediction that something is wrong — most of the time something ordinary is. They are the symptoms serious disease produces and ordinary trouble mostly does not, which is why guidelines route them straight to a look rather than to a trial of treatment. Here is the list, what each one is asking about, and how quickly it moves.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What an alarm symptom is, and what it earns

An alarm symptom is one that changes the plan by itself. It does not predict that something serious is present — most of the time it is not — and it is not a severity rating. It is a symptom that serious disease produces and that ordinary trouble mostly does not, which makes it worth acting on even when the odds behind it are reassuring. Guidelines treat that asymmetry as the entire point.

The concept comes out of the upper-GI literature first. The ACG and CAG dyspepsia guideline builds its pathway around it: with alarm features present, a person goes to upper endoscopy; without them, and under sixty, the recommendation is H. pylori test-and-treat, empiric acid suppression, or both 1. Same symptom, two roads, and the alarm feature is the switch that throws.

Downstream in the gut the logic is identical and the list is a little different. NIDDK's warning signs — the ones calling for prompt medical evaluation rather than watchful waiting — cover bleeding from the rectum, blood in the stool, pain that is constant rather than crampy, gas that will not pass, vomiting, and weight coming off unintentionally. A family history of colorectal cancer sits alongside them 2.

An alarm feature earns an evaluation, not a diagnosis. That distinction separates a page that helps from a page that frightens. Nothing on this list means you have cancer. Every item on it means the question deserves a real answer rather than a plausible one — and the reason the list stays short is that short lists actually get used.

The list, and what each item is asking

Each alarm feature is a question rather than a verdict, and the question is what determines which test answers it. Read the middle column as the thing a clinician is genuinely trying to find out. That is what you are agreeing to when you agree to a procedure, and it is a far more useful frame than the name of the symptom.

Alarm featureThe question it raisesWhere it points
Bleeding from the rectum, or blood in the stoolIs something in the bowel bleeding?The colon and rectum, usually
Weight coming off unintentionallyHas the illness begun to cost the whole body?Nowhere specific — it widens the search
Food sticking on the way downHas the esophagus narrowed or stopped working?Upward, to the esophagus
Pain that is constant rather than crampyIs something inflamed rather than squeezing?Depends where it sits
Vomiting, with no gas passing at allIs the tube blocked?Urgent, and not an outpatient question
A persistent change in bowel habitsHas the passage itself changed?The colon and rectum
Iron-deficiency anemia with no obvious sourceIs something bleeding where it cannot be seen?The whole tract, top to bottom
A first-degree relative with colorectal cancerDoes background risk change the threshold?Changes when to look, not what to look for

Notice what the right-hand column does. Half of these point somewhere specific and half do not — and the ones that do not are not the mild ones. Weight loss and anemia are among the most serious entries precisely because they refuse to say where they came from. A symptom that localizes gives a clinician somewhere to start; one that does not gives them a wider job 12.

Why "earns a colonoscopy" is slightly the wrong phrase

Because a symptom does not earn a particular instrument. It earns a look, and which look comes afterwards. This page is titled the way people search, but the honest version runs one step longer: the warning list earns prompt medical evaluation 2; the evaluation decides where to point a camera; and only then does a colonoscopy become the answer — or turn out not to be.

The distinction sounds pedantic until it costs something. People arrive at appointments having already decided which test they need, and the decision is often wrong in an expensive direction. A colonoscopy for a swallowing problem searches the wrong half of the body. A stool test for visible bleeding answers a question nobody asked.

When the colon is where the symptom points, colonoscopy is the first-tier instrument. The US Multi-Society Task Force ranks colonoscopy every ten years and annual FIT as its first-tier options, with stool DNA testing and CT colonography in the second tier 3. But read that ranking precisely, because it is a screening ranking. It is about how to look at people who feel well. It is not a statement about what to do for someone who is bleeding.

That is the pattern worth watching across this topic. Nearly every ranked, tiered, heavily evidenced statement about colonoscopy in the literature is a statement about screening. The evidence base for evaluating a symptom is thinner, more clinical, and far less tabulated — and the gap gets filled, by search results and insurers and occasionally by clinics, with screening logic applied where it was never built to go. The next two sections are the places that goes wrong: the ages, and the stool test.

The two age thresholds, and what each is actually for

Two numbers dominate this topic and they get swapped constantly. Forty-five is when screening begins for people with no symptoms. Sixty is when dyspepsia earns an upper endoscopy on age alone. Neither one is a threshold below which a symptom is allowed to wait, and reading them that way is the most common misuse of both.

Forty-five is a screening number. The US Preventive Services Task Force recommends colorectal cancer screening for average-risk adults starting at 45 — grade B from 45 to 49, grade A from 50 to 75, and a selective grade C from 76 to 85 4. Every word of that recommendation concerns average-risk people, and "average risk" is a technical phrase meaning, among other things, without symptoms. Someone with rectal bleeding is not an average-risk person. The age-45 screening change has nothing to say about them: it is neither a permission slip nor a barrier.

Sixty is a dyspepsia number. The ACG and CAG guideline routes a person of sixty or over with dyspepsia to upper endoscopy, while a person under sixty without alarm features gets test-and-treat, empiric acid suppression, or both 1. That threshold belongs to one symptom in the upper abdomen. It does not generalize to bowel symptoms at all, and it never governed them.

The error both numbers invite is the same, and it always runs the same direction: a person under the threshold concludes their symptom falls below the line. But these thresholds govern who gets looked at in the absence of a symptom, or in the absence of an alarm feature. A symptom is the thing that makes the threshold irrelevant. Alarm features route to endoscopy at any age — not only above sixty 1.

Worth being direct about the practical version of this. If a symptom on the list above is met with "you're too young for that," the useful reply is not an argument about statistics. It is a question: given that, what is the plan for finding out what this actually is?

Why a stool test is not an answer to a symptom

This is the most consequential misunderstanding on the topic, and it costs people months. A stool test is a screening instrument. It is built to be aimed at a population of people with no symptoms, repeated on a schedule, and judged on what the programme catches over years — not on what one test says about one person who is already bleeding.

The numbers make the case better than the argument does. A meta-analysis of the fecal immunochemical test found pooled sensitivity of about 0.79 and specificity of about 0.94 for colorectal cancer 5: moderately sensitive, highly specific. FIT misses roughly one in five colorectal cancers on a single test 5.

For screening, that is fine. Genuinely fine, not a compromise. The US Multi-Society Task Force ranks annual FIT alongside colonoscopy every ten years as a first-tier option 3, and the word carrying the load there is annual. A test catching four in five, repeated year after year across millions of people who feel well, finds an enormous amount of disease that would otherwise go unfound. The programme is the intervention; the single test is just one draw from it.

For a symptom, that same number is a trap. If you are bleeding and your FIT comes back negative, you have learned almost nothing — a test that misses one in five cancers among people with no symptoms has excluded nothing in a person who has one. And a positive result tells you what you already knew: there is blood. That was the observation that started the conversation. A stool test cannot rule out the thing a symptom is asking about. It was never built to.

There is a quieter version of this error that runs through scheduling rather than reasoning. A stool test is easy to order, arrives by post, needs no prep and no day off work, and so it becomes the path of least resistance for a busy clinic and a reluctant patient alike. An understandable way to end up in the wrong place — still the wrong place. Worth asking a prescriber directly whether a test is being ordered to screen you or to evaluate a symptom, because only one of those questions has a stool test as a reasonable answer.

Age is not a reason to discount a symptom

The alarm list carries no lower age bound, and this is where that matters most. American Cancer Society statistics report the share of colorectal cancer diagnosed under 55 roughly doubled — 11% in 1995 to 20% in 2019 — with a shift toward more advanced disease at diagnosis 6. The list does not get a discount because the person carrying the symptom is thirty-four.

That said, the alarm list is not a cancer list, and reading it as one is its own mistake. Most people with rectal bleeding do not have cancer. Most people with a changed bowel habit do not have cancer. These are not predictions — they are triggers, and a trigger is doing its job when it fires on the many in order to catch the few. A trigger that only fired when cancer was already likely would not be a trigger. It would be a diagnosis, arriving too late to be worth having.

Bleeding after 45 is a slightly different clinical object from bleeding at 25 — not because the younger person's bleeding needs no answer, but because the background rate behind an identical symptom differs, and background rate is what a clinician weighs when choosing which look to do first. Both people get evaluated. They may not get the same test, and that is a defensible difference rather than a dismissal.

Ibs versus colon cancer is where this gets genuinely hard, because a long-standing functional diagnosis is the most effective camouflage a new symptom can wear. The rule worth carrying: an existing diagnosis explains the symptoms it has always explained. It does not explain a new one. Someone with fifteen years of IBS who starts bleeding has a new symptom, and the IBS is not an answer to it — it is the thing that will make everyone in the room, including the patient, want to stop asking.

The alarm features that point up rather than down

Three of them route away from the colon entirely. The ACG and CAG dyspepsia guideline names unintended weight loss, gastrointestinal bleeding, and difficulty swallowing as the alarm features sending a person to upper endoscopy rather than to an empiric trial of acid suppression 1. Difficulty swallowing in particular is an esophageal question that a colonoscopy is anatomically incapable of answering.

This is where "which symptoms need a colonoscopy" stops being answerable as a list, because two of those three appear on both lists. Bleeding can come from either end of the tract, and the color is the clue: black and tarry means digested, which means it came from high up; red generally means it did not travel far. Weight loss points nowhere in particular, which is precisely why it widens the search instead of narrowing it.

  • Difficulty swallowing is the least ambiguous alarm feature in gastroenterology. Nothing benign reliably explains food sticking, and the fact that it can be worked around — chewing longer, drinking more, avoiding bread and meat — is what makes it dangerous rather than what makes it fine.
  • Bleeding from above looks different from bleeding below: coffee-ground vomit, or black tarry stool with no iron tablet behind it.
  • Weight loss is the entry that turns a focused question into a general one, and it belongs on every list for that reason.

When reflux rather than the bowel is the context, this same alarm logic runs a different pathway. When reflux needs a scope is a decision built on the same three features plus a trial of treatment, and it ends in an upper endoscopy rather than a colonoscopy.

The alarm feature decides that you get looked at. Where it points decides what does the looking.

How fast, and what to bring

NIDDK's word is prompt 2, and prompt does a lot of unspecified work. Here is a practical translation, offered as framing rather than as a rule: these are appointments measured in days and weeks rather than in wait-and-see months — and a small number of them are not appointments at all. The tiers below sort by how much time the symptom is willing to give you.

  • Now, and not as an appointment. Heavy bleeding, bleeding with dizziness or fainting, vomiting blood, or abdominal pain with vomiting and no gas passing at all.
  • Days. New rectal bleeding at any age. Weight coming off unintentionally. Food sticking on the way down. A bowel change that is new for you and has not reverted.
  • Weeks, but actually on the calendar. A family history nobody has ever mentioned to a clinician. A change that has been running for months without ever being assessed.

What you bring matters more than people expect, because this list is made of details that get rounded off in conversation. "Some blood" and "blood every day for three weeks, mixed through the stool rather than on it" are the same sentence to a patient and two different clinical objects to a clinician. Four things are worth writing down beforehand: when it started, what exactly you have seen, what came with it, and what your relatives had.

The warning digestive symptoms on this page are not a diagnosis and they are not a reason to panic. They are a reason to be specific and to be early, which are the two things that most reliably shorten the distance between a symptom and an answer.

Common questions

Bleeding earns prompt evaluation at any age — that part is not in question. Whether the look is a colonoscopy depends on your age, the character of the bleeding, your history, and what an examination finds, and that decision belongs to a clinician. What is clear is that bleeding is not a symptom to watch, and a normal stool test does not settle it.

No. FIT has pooled sensitivity of roughly 0.79 for colorectal cancer, meaning it misses about one in five on a single test. That is acceptable for annual screening of people with no symptoms, because the programme repeats. It is not a rule-out for someone who already has a symptom — a negative result in that situation has not answered the question you brought.

The age-45 recommendation is about screening average-risk adults, and average risk means without symptoms. It has nothing to say about someone who has one. Alarm features route to evaluation at any age. The share of colorectal cancer diagnosed under 55 roughly doubled between 1995 and 2019, which is one reason age alone is not a safe filter.

The question each answers. A screening colonoscopy looks at someone with no complaints on a schedule, to find polyps before they do anything. A diagnostic one investigates a symptom that already exists. Same procedure, different purpose — and the distinction also affects how the visit is coded and billed, which is worth clarifying with the practice before the day.

An existing diagnosis explains the symptoms it has always explained. It does not explain a new one. Someone with years of IBS who starts bleeding, loses weight without trying, or develops a bowel pattern unlike their usual has a new symptom, and the IBS label is the main reason it tends to get discounted — by everyone, including the person living with it.

Heavy bleeding, bleeding with fainting or dizziness, vomiting blood, or pain with vomiting and no gas passing is an emergency, not an appointment. New bleeding, unintended weight loss, food sticking, or a persistent new bowel change belong in the days-to-weeks range. The word guidelines use is prompt, and the failure mode is almost always waiting longer than that.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Which of these is not an appointment

  • Rectal bleeding that is heavy, or bleeding with dizziness, fainting, or a racing pulse
  • Vomiting blood, or vomit with the appearance of coffee grounds
  • Abdominal pain with vomiting and no gas or stool passing at all
  • Food that sticks on the way down, or swallowing that has become painful

Heavy rectal bleeding, blood with fainting or a racing pulse, vomiting blood, or abdominal pain with vomiting and nothing passing means the emergency department or 911 now — not a referral and not a stool test. The rest of the list on this page is a prompt appointment, which in practice means days.

This page explains the alarm features clinicians use to decide who needs a look inside, and why screening logic does not transfer to symptom evaluation. It is general education, not medical advice. It cannot examine you or choose your test — any symptom on this list is worth taking to a clinician who can.

References

  1. 1.Moayyedi P, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N (2017). ACG and CAG Clinical Guideline: Management of Dyspepsia. American Journal of Gastroenterology. doi:10.1038/ajg.2017.154The alarm-feature concept and its list (unintended weight loss, gastrointestinal bleeding, difficulty swallowing), the routing of alarm features to upper endoscopy regardless of age, the age-60 threshold for endoscopy in dyspepsia, and H. pylori test-and-treat or empiric acid suppression for those under 60 without alarm features.
  2. 2.National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2018). Symptoms & Causes of Constipation. NIDDK, National Institutes of Health. linkThe lower-GI warning signs calling for prompt medical evaluation — rectal bleeding, blood in the stool, constant abdominal pain, inability to pass gas, vomiting, unintentional weight loss — and the inclusion of a family history of colorectal cancer alongside them.
  3. 3.Rex DK, Boland CR, Dominitz JA, et al. (U.S. Multi-Society Task Force on Colorectal Cancer) (2017). Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointestinal Endoscopy. doi:10.1016/j.gie.2017.04.003That colonoscopy every ten years and annual FIT are ranked first-tier colorectal cancer screening options, with stool DNA testing and CT colonography in the second tier — and that this ranking is a screening framework rather than a symptom-evaluation one.
  4. 4.U.S. Preventive Services Task Force (USPSTF) (2021). Colorectal Cancer: Screening (Final Recommendation). U.S. Preventive Services Task Force. linkThat recommended colorectal cancer screening for average-risk adults begins at 45 — grade B for 45-49, grade A for 50-75, selective grade C for 76-85 — and that the recommendation applies to average-risk (asymptomatic) adults.
  5. 5.Lee JK, Liles EG, Bent S, Levin TR, Corley DA (2014). Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Annals of Internal Medicine. doi:10.7326/M13-1484That FIT has pooled sensitivity of approximately 0.79 and specificity of approximately 0.94 for colorectal cancer — moderately sensitive and highly specific — which is the basis for the statement that a single FIT misses roughly one in five colorectal cancers.
  6. 6.Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A (2023). Colorectal cancer statistics, 2023. CA: A Cancer Journal for Clinicians. doi:10.3322/caac.21772That the share of colorectal cancer diagnosed in adults under 55 roughly doubled from 11% in 1995 to 20% in 2019, with a shift toward more advanced-stage disease at diagnosis.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy